-
FDA Approves First New Measles, Mumps and Rubella Vaccine in 50 Years
GlaxoSmithKline (GSK) today announced that the U.S. Food and Drug Administration (FDA) has approved its measles, mumps and rubella vaccine Priorix for...
2022-06-07 10:28 -
FDA Breakthrough Therapy Designation for Topical Vitamin A Derivatives to Treat Inherited Skin Disea...
Recently, Timber Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation to its invest...
2022-06-06 16:04 -
Roche to Introduce ATR Inhibitor RP-3500 for $1.2 Billion
On June 1, Repare Therapeutics announced that it has entered into a global license and collaboration agreement with Roche for the development and comm...
2022-06-02 13:45 -
An Innovative Protein Degrader Targeting STAT3 Receives FDA Orphan Drug Designation
Kymera Therapeutics announced today that the U.S. Food and Drug Administration has granted orphan drug designation to its investigational protein degr...
2022-06-02 13:43 -
Takeda Refunds Japan Rights to Moderna's COVID-19 Vaccine Spikevax
On May 31, Takeda announced that, effective August 1, 2022, the company will return to Moderna the commercialization rights of Moderna's new coronary ...
2022-06-01 14:15 -
Johnson & Johnson BTK Inhibitor Ibrutinib New Indication for Listing
On May 31, the CDE official website showed that Johnson & Johnson’s new indications for ibrutinib capsules (Imbruvica, Yike) have been accepted for m...
2022-06-01 11:39 -
4 Innovative Drugs are Expected to be Approved by the FDA in June
Boehringer Ingelheim's spesolimab, a humanized selective antibody that blocks activation of the interleukin-36 receptor (IL-36R), is seeking FDA appro...
2022-05-31 16:35 -
U.S. FDA Halts Sanofi's Cialis Over-the-counter Drug Trial Amid Doubts Over Program Design
A few days ago, the U.S. Food and Drug Administration (FDA) said it has decided to immediately suspend the actual use trial of Sanofi’s prescription ...
2022-05-31 16:28 -
Competitive Landscape of China's Biosimilars Market
Since 2015, with the introduction of a series of policies by the state to encourage the development of domestic biosimilars, many returnee doctors hav...
2022-05-30 17:38 -
GlaxoSmithKline HPV Vaccine Two-dose Schedule Approved in China
Recently, GlaxoSmithKline (GSK) announced that, according to the review results of the National Medical Products Administration (NMPA)
2022-05-30 17:27
Hot News
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Europe Faces Unprecedented Pet... Jul 23, 2025
- Sally Beauty Acquires Flair Ha... Jul 07, 2025
- Guangdong Jieyang Puts into Op... Jul 16, 2025
Related Products